Joseph Douglas Mancias, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Coactivators | 8 | 2022 | 59 | 2.880 |
Why?
|
| Autophagy | 14 | 2023 | 1300 | 1.610 |
Why?
|
| Carcinoma, Pancreatic Ductal | 15 | 2024 | 1634 | 1.570 |
Why?
|
| Erythropoiesis | 3 | 2019 | 705 | 1.420 |
Why?
|
| Pancreatic Neoplasms | 21 | 2024 | 5256 | 1.290 |
Why?
|
| Ferritins | 6 | 2023 | 590 | 1.240 |
Why?
|
| Iron | 9 | 2023 | 1774 | 1.140 |
Why?
|
| Iron-Sulfur Proteins | 2 | 2022 | 82 | 1.050 |
Why?
|
| COP-Coated Vesicles | 5 | 2008 | 41 | 0.840 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 6 | 2022 | 1692 | 0.630 |
Why?
|
| Proteomics | 7 | 2021 | 3638 | 0.600 |
Why?
|
| Phagosomes | 2 | 2015 | 193 | 0.560 |
Why?
|
| Radiosurgery | 5 | 2023 | 1329 | 0.520 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 871 | 0.500 |
Why?
|
| Oncogenes | 1 | 2020 | 1265 | 0.470 |
Why?
|
| Anemia | 2 | 2022 | 1506 | 0.450 |
Why?
|
| Homeostasis | 5 | 2023 | 3340 | 0.430 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 581 | 0.400 |
Why?
|
| Adenocarcinoma | 8 | 2022 | 6364 | 0.380 |
Why?
|
| Biological Availability | 3 | 2022 | 397 | 0.370 |
Why?
|
| Protein Sorting Signals | 2 | 2008 | 281 | 0.360 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2021 | 1366 | 0.350 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1403 | 0.320 |
Why?
|
| Endoplasmic Reticulum | 4 | 2008 | 1144 | 0.320 |
Why?
|
| R-SNARE Proteins | 1 | 2007 | 74 | 0.300 |
Why?
|
| Peptide Hydrolases | 2 | 2020 | 634 | 0.280 |
Why?
|
| Neoplasms | 7 | 2023 | 21683 | 0.260 |
Why?
|
| Sulfur | 2 | 2022 | 166 | 0.260 |
Why?
|
| Proteome | 3 | 2021 | 1799 | 0.260 |
Why?
|
| Vesicular Transport Proteins | 4 | 2008 | 377 | 0.250 |
Why?
|
| Lysosomes | 4 | 2021 | 893 | 0.240 |
Why?
|
| Protein Folding | 1 | 2007 | 843 | 0.230 |
Why?
|
| Glutamine | 2 | 2017 | 578 | 0.210 |
Why?
|
| Glyceraldehyde | 1 | 2021 | 5 | 0.210 |
Why?
|
| Propane | 1 | 2021 | 11 | 0.210 |
Why?
|
| Comprehension | 2 | 2018 | 610 | 0.210 |
Why?
|
| Wolfram Syndrome | 1 | 2021 | 13 | 0.210 |
Why?
|
| Animals | 27 | 2023 | 168757 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2020 | 2915 | 0.200 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2021 | 35 | 0.190 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2021 | 76 | 0.190 |
Why?
|
| Cell Proliferation | 7 | 2021 | 10481 | 0.190 |
Why?
|
| Mice | 17 | 2023 | 81183 | 0.190 |
Why?
|
| Particle Accelerators | 1 | 2021 | 173 | 0.190 |
Why?
|
| Hemochromatosis | 1 | 2022 | 184 | 0.190 |
Why?
|
| Cell Line, Tumor | 10 | 2023 | 16689 | 0.190 |
Why?
|
| Sex Reassignment Surgery | 1 | 2023 | 130 | 0.190 |
Why?
|
| Epitopes | 1 | 2007 | 2571 | 0.180 |
Why?
|
| Ameloblasts | 1 | 2020 | 17 | 0.180 |
Why?
|
| Protein Transport | 4 | 2014 | 1988 | 0.180 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2021 | 215 | 0.180 |
Why?
|
| Iron Overload | 1 | 2022 | 242 | 0.180 |
Why?
|
| Cell Respiration | 1 | 2020 | 201 | 0.180 |
Why?
|
| Prenylation | 1 | 2019 | 37 | 0.180 |
Why?
|
| Phagocytes | 1 | 2021 | 297 | 0.170 |
Why?
|
| Colonic Neoplasms | 2 | 2023 | 2541 | 0.170 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 290 | 0.170 |
Why?
|
| Incisor | 1 | 2020 | 179 | 0.170 |
Why?
|
| Crystallography, X-Ray | 5 | 2018 | 2011 | 0.170 |
Why?
|
| Transcription Factors | 5 | 2022 | 12208 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2021 | 3557 | 0.160 |
Why?
|
| Alanine | 1 | 2020 | 572 | 0.150 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2019 | 246 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2020 | 349 | 0.150 |
Why?
|
| K562 Cells | 1 | 2019 | 634 | 0.150 |
Why?
|
| Biological Assay | 2 | 2021 | 652 | 0.140 |
Why?
|
| Serine | 1 | 2020 | 826 | 0.140 |
Why?
|
| Hemolysis | 1 | 2019 | 420 | 0.140 |
Why?
|
| Humans | 48 | 2024 | 744343 | 0.140 |
Why?
|
| Mutation | 3 | 2020 | 29786 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2020 | 783 | 0.140 |
Why?
|
| Centrioles | 1 | 2016 | 79 | 0.140 |
Why?
|
| Acetamides | 1 | 2018 | 249 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2187 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 1114 | 0.140 |
Why?
|
| Cysteine | 1 | 2021 | 874 | 0.140 |
Why?
|
| Protein Kinases | 1 | 2023 | 1640 | 0.130 |
Why?
|
| Chloroquine | 2 | 2020 | 280 | 0.130 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2016 | 249 | 0.130 |
Why?
|
| Internet | 2 | 2018 | 3064 | 0.130 |
Why?
|
| Models, Molecular | 5 | 2020 | 5456 | 0.130 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 692 | 0.130 |
Why?
|
| Pancreatectomy | 1 | 2019 | 804 | 0.130 |
Why?
|
| Protein Binding | 4 | 2014 | 9386 | 0.120 |
Why?
|
| Amino Acids | 1 | 2021 | 1736 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2008 | 7880 | 0.120 |
Why?
|
| RNA | 2 | 2023 | 2749 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2023 | 1861 | 0.120 |
Why?
|
| Consumer Health Information | 1 | 2016 | 211 | 0.120 |
Why?
|
| Mitochondria | 3 | 2023 | 3520 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2007 | 5021 | 0.120 |
Why?
|
| Thiophenes | 1 | 2018 | 588 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2015 | 424 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 2126 | 0.110 |
Why?
|
| Thalidomide | 1 | 2018 | 890 | 0.110 |
Why?
|
| Cell Line | 4 | 2020 | 15997 | 0.110 |
Why?
|
| Neoadjuvant Therapy | 2 | 2022 | 2728 | 0.110 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 6773 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2020 | 3002 | 0.110 |
Why?
|
| Doxorubicin | 1 | 2019 | 2234 | 0.110 |
Why?
|
| Microcephaly | 1 | 2016 | 432 | 0.110 |
Why?
|
| Zebrafish | 3 | 2020 | 2994 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1788 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 1086 | 0.100 |
Why?
|
| Models, Biological | 3 | 2021 | 9583 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2020 | 4217 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2019 | 2969 | 0.090 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 3 | 2023 | 1624 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2014 | 1801 | 0.090 |
Why?
|
| Lymphoma | 1 | 2019 | 1877 | 0.090 |
Why?
|
| Protein Structure, Secondary | 3 | 2008 | 1246 | 0.090 |
Why?
|
| Qb-SNARE Proteins | 1 | 2008 | 36 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 21827 | 0.080 |
Why?
|
| Genes, ras | 1 | 2011 | 690 | 0.080 |
Why?
|
| Qa-SNARE Proteins | 1 | 2008 | 55 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2021 | 23403 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2018 | 3462 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 1152 | 0.080 |
Why?
|
| ras Proteins | 1 | 2014 | 1060 | 0.080 |
Why?
|
| Immunotherapy | 2 | 2021 | 4445 | 0.080 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 3086 | 0.080 |
Why?
|
| Hydroxychloroquine | 1 | 2011 | 412 | 0.080 |
Why?
|
| Carcinoma | 1 | 2019 | 2375 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 2916 | 0.080 |
Why?
|
| Binding Sites | 3 | 2018 | 6114 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2022 | 5535 | 0.070 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 2203 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 18111 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14557 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11524 | 0.070 |
Why?
|
| SNARE Proteins | 1 | 2007 | 88 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2023 | 8428 | 0.070 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2007 | 199 | 0.070 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2007 | 165 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 13695 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2020 | 1899 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 3523 | 0.070 |
Why?
|
| Amino Acid Sequence | 4 | 2019 | 13815 | 0.070 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 3586 | 0.070 |
Why?
|
| Proteins | 1 | 2020 | 6103 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2008 | 1202 | 0.060 |
Why?
|
| Cricetinae | 1 | 2008 | 2472 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2024 | 2499 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1730 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4462 | 0.060 |
Why?
|
| Pancreas | 2 | 2023 | 1686 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10180 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2024 | 4479 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5853 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2023 | 3760 | 0.050 |
Why?
|
| Male | 14 | 2023 | 350118 | 0.050 |
Why?
|
| Biological Transport | 1 | 2007 | 2118 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2007 | 4011 | 0.050 |
Why?
|
| Claudins | 1 | 2023 | 111 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 12072 | 0.050 |
Why?
|
| Glucose | 1 | 2014 | 4397 | 0.050 |
Why?
|
| Ligands | 2 | 2019 | 3282 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2007 | 1028 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 4554 | 0.050 |
Why?
|
| Neurons | 1 | 2020 | 9338 | 0.050 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2020 | 39 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8664 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 1119 | 0.050 |
Why?
|
| Female | 13 | 2023 | 380194 | 0.050 |
Why?
|
| Nerve Tissue | 1 | 2020 | 79 | 0.050 |
Why?
|
| Enterocytes | 1 | 2022 | 225 | 0.050 |
Why?
|
| Anal Canal | 1 | 2023 | 376 | 0.050 |
Why?
|
| Fiducial Markers | 1 | 2021 | 136 | 0.050 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2020 | 195 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 203 | 0.040 |
Why?
|
| Glutathione | 1 | 2021 | 589 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11483 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2016 | 6196 | 0.040 |
Why?
|
| Codon | 1 | 2020 | 611 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 3772 | 0.040 |
Why?
|
| Metagenomics | 1 | 2021 | 428 | 0.040 |
Why?
|
| Time Factors | 1 | 2020 | 40075 | 0.040 |
Why?
|
| Peptide Library | 1 | 1999 | 349 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2020 | 316 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2019 | 408 | 0.040 |
Why?
|
| Vagina | 1 | 2023 | 825 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 675 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 428 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2007 | 1888 | 0.040 |
Why?
|
| Glutaminase | 1 | 2017 | 35 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 809 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 730 | 0.040 |
Why?
|
| Glycine | 1 | 2020 | 671 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2018 | 563 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 1821 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2023 | 2879 | 0.030 |
Why?
|
| Organizations, Nonprofit | 1 | 2016 | 104 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1878 | 0.030 |
Why?
|
| Government | 1 | 2016 | 165 | 0.030 |
Why?
|
| Selection Bias | 1 | 2017 | 371 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2016 | 408 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2005 | 3748 | 0.030 |
Why?
|
| Leucovorin | 1 | 2016 | 628 | 0.030 |
Why?
|
| Epithelium | 1 | 2020 | 1679 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 2540 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2016 | 549 | 0.030 |
Why?
|
| Amyloid | 1 | 1999 | 795 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 336 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2020 | 1284 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 3129 | 0.030 |
Why?
|
| Aged | 6 | 2023 | 163280 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2020 | 2088 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 905 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2020 | 1869 | 0.030 |
Why?
|
| Pinocytosis | 1 | 2014 | 65 | 0.030 |
Why?
|
| Ownership | 1 | 2016 | 332 | 0.030 |
Why?
|
| Rats | 2 | 2020 | 24260 | 0.030 |
Why?
|
| Models, Animal | 1 | 2020 | 2171 | 0.030 |
Why?
|
| Prostate | 1 | 2022 | 1774 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 3846 | 0.030 |
Why?
|
| Mass Media | 1 | 2016 | 305 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2019 | 7729 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 976 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2077 | 0.030 |
Why?
|
| Metabolomics | 1 | 2021 | 1484 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2021 | 2480 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2021 | 3206 | 0.030 |
Why?
|
| Axons | 1 | 2020 | 1684 | 0.030 |
Why?
|
| Complementary Therapies | 1 | 2016 | 486 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2016 | 1619 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2020 | 2751 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 4644 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4204 | 0.020 |
Why?
|
| Stents | 1 | 2023 | 3280 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 6314 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 1157 | 0.020 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2017 | 806 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2019 | 1058 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 3036 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3086 | 0.020 |
Why?
|
| Middle Aged | 6 | 2020 | 213383 | 0.020 |
Why?
|
| Propensity Score | 1 | 2017 | 1781 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2899 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2020 | 1972 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 26385 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2014 | 1726 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 5179 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2020 | 2942 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2016 | 1099 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5217 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3690 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8642 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77449 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9734 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3507 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2016 | 19229 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10252 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6538 | 0.020 |
Why?
|
| Macrophages | 1 | 2021 | 5655 | 0.020 |
Why?
|
| Mass Screening | 1 | 2022 | 5255 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 2278 | 0.020 |
Why?
|
| Clathrin | 1 | 2007 | 267 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2759 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2007 | 410 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2020 | 13033 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 2007 | 1454 | 0.020 |
Why?
|
| Incidence | 1 | 2022 | 20947 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18029 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1791 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29063 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 13881 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7913 | 0.010 |
Why?
|
| United States | 2 | 2019 | 69872 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7279 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2023 | 53288 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2007 | 2752 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 214055 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63114 | 0.010 |
Why?
|